Finally, in the series of IBC patient samples, we demonstrated that MYC transcriptional activation, calculated based on the target gene set published by Muhar et al.32 was positively associated to MYC (P < 0.001), NMYC (P = 0.017), MLX (P = 0.045) and MXD3 (P < 0.001) and negatively to MAX (P < 0.001). The gene discussed is MXD3; the disease is inflammatory breast carcinoma.